Saudi Guideline for Dyslipidemia Management (2022) Ahmad M. Al-Ahmadi

Description

A national clinical practice guideline for the management of dyslipidemia, focusing on cardiovascular risk assessment, lifestyle modifications, and pharmacological treatments. Key topics include managing cholesterol, triglycerides, and lipoproteins, and utilizing drug therapies such as statins, ezetimibe, PCSK9 inhibitors, and Inclisiran for primary and secondary prevention of cardiovascular disease.